Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients
This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…
Certara2026 年 1 月 22 日
Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy
Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…
Certara2026 年 1 月 22 日
Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus
Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…
Certara2026 年 1 月 16 日
Regulatory Horizons: Strategic Global Insights & 2026 Outlook from Former Leaders of Major Regulatory Agencies
Watch this on-demand webinar featuring former regulators as they share global regulatory trends and clinical…
Certara2026 年 1 月 14 日
Delivering on deadline: Why pharmacometrics (pmx) is the anchor of successful regulatory submissions
Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…
Certara2025 年 12 月 29 日
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection
This study synthesizes data from a large body of clinical trials to evaluate rates of…
Certara2025 年 12 月 18 日
